Development of the Composition and Manufacturing Technology of a New Combined Drug: Lavaflam

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2018, Vol 15, Issue 3

Abstract

Objectives: Treatment of diseaes of the biliary system is one of the urgent problems of modern medicine. Materials and Methods: An original pharmaceutical drug “Lavaflam” in the form of combined tablets, which includes a composition of herbal components flamin (0.05 g) and lavender oil (0.02 g), was proposed for the complex treatment of diseases of the biliary system. Flamin is phytomedicine from the immortelle flowers [Helichrysum arenarium (L.) Moench, Asteraceae], which contains a complex of active substances from the flavonoids group (salipurposide, isosalipurposide, kaempferol, luteolin). It is applied as a choleretic and an anti-inflammatory agent in cholecystitis, cholangitis, and biliary dyskinesia. Tablets were prepared by pressing for separate granulation technology. Results: The lavender oil granulate was prepared using the solid phase method, and β-cyclodextrin was used as an excipient substance. The flamin granulate was prepared by mixing with the spherical-shaped filler mannitol PARTECK M 200. On the basis of previous studies, the excipients of the designed composition tablet “Lavaflam” were β-cyclodextrin (0.27 g), mannitol PARTECK M 200 (0.20 g), croscarmellose sodium (0.03 g), potato starch (0.022 g), PEG 6000 (0.002 g), and magnesium stearate (0.006 g). The assay of the main components of lavender oil with the references linalol and linalyl acetate was performed using gas chromatography. The assay of the total flavonoids of flamin was performed using spectrophotometry with isosalipurposide as the reference. Conclusion: The new phytomedicine tablets “Lavaflam” meet European Pharmacopoeia requirements on the following parameters: appearance, geometric size, average weight, disintegration, friability, resistance of tablets to crushing, and quantification.

Authors and Affiliations

Tanya IVKO, Milena ASLANIAN, Larisa BOBRYTSKA, Natalia POPOVA, Olena NAZAROVA, Tamara GERMANYUK

Keywords

Related Articles

Structure Elucidation and Antimicrobial Activities of Secondary Metabolites from the Flowery Parts of Verbascum mucronatum Lam.

Objectives: To determine the secondary metabolites from Verbascum mucronatum Lam. and evaluate their antimicrobial activity. Materials and Methods: Antimicrobial activities of the isolated metabolites were determined usi...

Investigation of Antimicrobial Activities of Some Herbs Containing Essential Oils and Their Mouthwash Formulations

Objectives: The aim of this study was to prepare pharmaceutical formulations of mouthwashes and to examine the antimicrobial activities of essential oils obtained from plants used traditionally in Turkey for oral infecti...

Quantitative Structure–Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents

Objectives: To understand the role of Rho (serine/threonine) kinases in the treatment of neurological segments, attempts have been made to find potent inhibitors of Rho enzyme by a 2D quantitative structure–activity rela...

Synthesis and Hypoglycemic and Anti-inflammatory Activity Screening of Novel Substituted 5-[Morpholino(Phenyl)Methyl]-Thiazolidine-2,4-Diones and Their Molecular Docking Studies

Objectives: The aim was the synthesis of novel substituted 5-[morpholino(phenyl)methyl]-thiazolidine-2,4-diones and screening for their in vivo hypoglycemic activity and in vitro anti-inflammatory activity, as well as mo...

Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers

Objectives: Extracellular matrix components, including vitronectin (VN), soluble epithelial-cadherin (sE-cadherin) and transforming growth factor-beta 1 (TGF-β1), play a key role in the invasion and metastasis of cancer....

Download PDF file
  • EP ID EP421229
  • DOI 10.4274/tjps.79553
  • Views 151
  • Downloads 0

How To Cite

Tanya IVKO, Milena ASLANIAN, Larisa BOBRYTSKA, Natalia POPOVA, Olena NAZAROVA, Tamara GERMANYUK (2018). Development of the Composition and Manufacturing Technology of a New Combined Drug: Lavaflam. Turkish Journal of Pharmaceutical Sciences, 15(3), 263-270. https://www.europub.co.uk/articles/-A-421229